SK biopharmaceuticals

SK biopharmaceuticals

Developing innovative and next-generation drugs for central nervous system.

HQ location
Seongnam-si, South Korea
Website
Launch date
Market cap
$6.0b
Enterprise value
$5.9b
Share price
KRW92500.00 326030.KS
Authorizing premium user...